Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer

Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer

<p>Abstract</p> <p>Background</p> <p>The clinical implication of Ras/Raf/ERK pathway activity in breast cancer tissue and its association with response to chemotherapy is controversial. We aimed to explore the value of p90RSK phosphorylation, a downstram molecule of the...

Descrición completa

Detalles Bibliográficos
Main Authors: Moon Hyeong-Gon, Yi Jae, Kim Hee, Lee Hea, Lee Kyung-Min, Yi Minju, Ahn Sookyung, Shin Hee-Chul, Ju Ji-hyun, Shin Incheol, Han Wonshik, Noh Dong-Young
Formato: Artigo
Idioma:English
Publicado: BMC 2012-12-01
Series:BMC Cancer
Subjects:
Breast cancer
P90RSK
Chemotherapy
Predictive marker
ERK
Estrogen receptor
Acceso en liña:http://www.biomedcentral.com/1471-2407/12/585

Títulos similares

Títulos similares